432d

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:432d.gif|left|200px]]
[[Image:432d.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 432d |SIZE=350|CAPTION= <scene name='initialview01'>432d</scene>, resolution 1.89&Aring;
+
The line below this paragraph, containing "STRUCTURE_432d", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=DA:2&#39;-DEOXYADENOSINE-5&#39;-MONOPHOSPHATE'>DA</scene>, <scene name='pdbligand=DAP:6-AMIDINE-2-(4-AMIDINO-PHENYL)INDOLE'>DAP</scene>, <scene name='pdbligand=DC:2&#39;-DEOXYCYTIDINE-5&#39;-MONOPHOSPHATE'>DC</scene>, <scene name='pdbligand=DG:2&#39;-DEOXYGUANOSINE-5&#39;-MONOPHOSPHATE'>DG</scene>, <scene name='pdbligand=DT:THYMIDINE-5&#39;-MONOPHOSPHATE'>DT</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE=
+
-->
-
|DOMAIN=
+
{{STRUCTURE_432d| PDB=432d | SCENE= }}
-
|RELATEDENTRY=
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=432d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=432d OCA], [http://www.ebi.ac.uk/pdbsum/432d PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=432d RCSB]</span>
+
-
}}
+
'''D(GGCCAATTGG) COMPLEXED WITH DAPI'''
'''D(GGCCAATTGG) COMPLEXED WITH DAPI'''
Line 19: Line 16:
==About this Structure==
==About this Structure==
-
432D is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/ ]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=432D OCA].
+
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=432D OCA].
==Reference==
==Reference==
Crystal structure of d(GGCCAATTGG) complexed with DAPI reveals novel binding mode., Vlieghe D, Sponer J, Van Meervelt L, Biochemistry. 1999 Dec 14;38(50):16443-51. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10600105 10600105]
Crystal structure of d(GGCCAATTGG) complexed with DAPI reveals novel binding mode., Vlieghe D, Sponer J, Van Meervelt L, Biochemistry. 1999 Dec 14;38(50):16443-51. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10600105 10600105]
-
[[Category: Protein complex]]
 
[[Category: Meervelt, L Van.]]
[[Category: Meervelt, L Van.]]
[[Category: Vlieghe, D.]]
[[Category: Vlieghe, D.]]
[[Category: 4',6-diamidino-2-phenyl indole]]
[[Category: 4',6-diamidino-2-phenyl indole]]
-
[[Category: dapi]]
+
[[Category: Dapi]]
-
[[Category: deoxyribonucleic acid]]
+
[[Category: Deoxyribonucleic acid]]
-
[[Category: dna-drug complex]]
+
[[Category: Dna-drug complex]]
-
[[Category: minor groove binder]]
+
[[Category: Minor groove binder]]
-
[[Category: triplet formation]]
+
[[Category: Triplet formation]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 22:17:32 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 05:37:09 2008''
+

Revision as of 19:17, 4 May 2008

Template:STRUCTURE 432d

D(GGCCAATTGG) COMPLEXED WITH DAPI


Overview

The single-crystal X-ray structure of the complex between the minor groove binder 4',6-diamidino-2-phenylindole (DAPI) and d(GGCCAATTGG) reveals a novel way of off-centered binding, with an unique hydrogen bond between the minor groove binder and a CG base pair. Application of crystal engineering and cryocooling techniques helped to extend the resolution to 1.9 A, resulting in an unambiguous determination of drug conformation and orientation. The structure was refined to completion using SHELXL-93, resulting in a residual factor R of 18. 0% for 3562 reflections with F(o) > 4sigma(F(o)) including 81 water molecules. As the bulky NH(2)-group on guanine is believed to prevent drug binding in the minor groove, the nature and stability of the CG-DAPI contact was further addressed in full detail using ab initio quantum chemical methods. The amino groups involved in the guanine-drug interaction are substantially nonplanar, resulting in an energy gain of about 5 kcal/mol. The combined structural and theoretical data suggest that the guanine NH(2)-group does not destabilize the drug binding to an extent that it prevents complexation.

About this Structure

Full crystallographic information is available from OCA.

Reference

Crystal structure of d(GGCCAATTGG) complexed with DAPI reveals novel binding mode., Vlieghe D, Sponer J, Van Meervelt L, Biochemistry. 1999 Dec 14;38(50):16443-51. PMID:10600105 Page seeded by OCA on Sun May 4 22:17:32 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools